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Interpretative Summary 1 
In vitro digested milk proteins: evaluation of Angiotensin-1-Converting Enzyme 2 
Inhibitory and antioxidant activities, peptidomic profile and mucin gene expression in 3 
HT29-MTX cells 4 
by Giromini et al. We studied the bioactive effect of in vitro digested whey protein isolate 5 
(WPI), casein proteins (CP) and soy proteins (CTR) in term of Angiotensin-1-Converting 6 
Enzyme Inhibitory activity (ACE1-I), antioxidant (AOX) and intestinal HT29-MTX-E12 cell 7 
metabolic activity and mucus-production. Our results indicate that milk proteins possess higher 8 
AOX and ACE1-I activity after in vitro digestion. Peptidomic analysis reveal that WPI and CP 9 
generated potentially bioactive peptides mainly associated to ACE1-I bioactivity. We also 10 
reported that specific concentrations of WPI, CP and CTR are able to promote HT29-MTX-E12 11 
cells metabolic activity and, in the case of CP, the MUC5AC and MUC2 gene expression, 12 
suggesting that the consumption of milk proteins can have a positive effect on intestinal 13 
defenses.  14 
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Over the past decades, a number of studies investigated the health-promoting functions of milk 33 
peptides. However, to date many hurdles still exist regarding the widespread utilization of milk-34 
derived bioactive peptides as they may be degraded during gastrointestinal digestion. Thus, the 35 
aim our study was to in vitro digest intact Whey Proteins Isolate (WPI) and Casein Proteins 36 
(CP), mimicking in vivo digestion, to investigate their bioactive effects and to identify the 37 
potential peptides involved. Whey protein isolate and CP were digested using a 38 
pepsin/pancreatin protocol and ultra-filtered (3kDa cut-off membrane). A permeate (<3kDa) 39 
and a retentate (>3kDa) were obtained. Soya protein was included as a control (CTR). 40 
Angiotensin-1-Converting Enzyme Inhibitory (ACE1-I) and Antioxidant activity (AOX) were 41 
assessed and compared with those observed in undigested proteins and CTR. Furthermore, the 42 
permeate was characterized by LC-nano ESI MS/MS using a shotgun-peptidomic approach 43 
while retentate was further digested with trypsin and analysed by mass spectrometry with a 44 
shotgun-proteomic approach to identify  potentially bioactive peptides. Further, the effect of 45 
WPI, CP and CTR retentate on cell metabolic activity and on mucus production (MUC5AC and 46 
MUC 2 gene expression) was assessed in intestinal goblet HT29-MTX-E12 cells. Results 47 
showed that WPI permeate induced a significant ACE1-I inhibitory effect (49.2 ± 0.64 %) 48 
compared with undigested WPI, CP permeate and retentate (P<0.001) and with CTR permeate 49 
(10.40 ± 1.07 %; P<0.001). A significant increase in AOX (1.58 ± 0.04 and 1.61 ± 0.02 µmol 50 
trolox AOX equivalents /mg protein, respectively) upon digestion was found in WPI. 51 
Potentially bioactive peptides associated with ACE1-I and anti-hypertensive effects were 52 
identified in WPI permeate and CP retentate. WPI, CP and CTR retentate, at specific 53 
concentrations, were able to stimulate (P<0.05) metabolic activity in HT29-MTX-E12 cells; 54 
MUC5AC expression was increased (P<0.05) by CP retentate and unaltered (P>0.1) by WPI 55 
retentate. MUC2 expression was significantly increased by 0.33 mg/g CP and reduced by 1.33 56 
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mg/g CP. Our results confirm that milk proteins may be rich sources of bioactive compounds 57 
with a greatest beneficial potential of CP at intestinal goblet cell level. 58 
KEYWORDS: milk protein; in vitro digestion; peptidomic; angiotensin-I-converting enzyme. 59 
 60 
INTRODUCTION 61 
Milk proteins are considered one of the most important source of bioactive peptides. Beyond 62 
their well-known nutritional values, milk proteins exhibit an extensive range of physiological 63 
effects that promote general health and the functions of specific organs and tissues (Meisel and 64 
FitzGerald, 2003; Martínez-Maqueda et al., 2012b). The most relevant functional properties of 65 
milk proteins are obtained following gastrointestinal digestion and milk peptides release (Baldi 66 
et al., 2005; Vermeirssen et al., 2003). A recent study compared the peptidome of human jejunal 67 
effluents after ingestion of casein and whey proteins with the peptidome obtained after their in 68 
vitro gastrointestinal digestion. This study has allowed the identification of protein domains 69 
that are resistant to gastrointestinal digestion (Sanchón et al., 2018). Some of these peptide 70 
fragments correspond to previously described sequences that might exert their physiological 71 
function at the intestinal epithelium level or after absorption where they can elicit unique effects 72 
(Shimizu, 2004). It has been reported that peptides from the hydrolysis of milk proteins possess 73 
functional properties such as antioxidant, angiotensin-I-converting enzyme inhibitory activity, 74 
antimicrobial and cytomodulatory activities (Baldi et al., 2005; Martìnez-Maqueda et al., 75 
2012b; Giromini et al., 2017). Petrat-Melin et al. (2015) found that beta-casein variants 76 
exhibited antioxidant and angiotensin-I-converting enzyme inhibitory activity upon digestion. 77 
Furthermore, larger peptides from milk protein digestion pool (i.e >3kDa) are unlikely to reach 78 
the bloodstream and will therefore mediate their bioactive effect locally, at gastro intestinal 79 
level (Miner-Williams et al., 2014). Beta-casomorphin 7, a casein-derived peptide, exhibited an 80 
enhanced mucin gene expression mediated by opioid receptors in intestinal goblet cells (Zoghbi 81 
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et al., 2006). To date, however, most attention has been focused on the bioactive effect of single 82 
peptides or hydrolysed proteins (Martínez-Maqueda et al., 2012a; Plaisaincié et al., 2015) with 83 
limited data on the effect of the whole pool of peptides obtained after in vitro digestion of milk 84 
proteins (Mukhopadhya et al., 2015; Volstatova et al., 2016), their potential mechanism of 85 
action and the candidate peptides involved. Casein and whey proteins, however, are present in 86 
milk and dairy products in their intact form and the total peptide pool produced from their 87 
digestion may have diverse effects in vivo. Evidences from robust in vitro studies simulating 88 
protein digestion, and the subsequent evaluation of the bioactive effect could offer invaluable 89 
information on the physiological mechanisms by which these proteins may elicit their biological 90 
effect in vivo. Consequently, we investigated the ACE1-Inhibitory (ACE1-I) and antioxidant 91 
(AOX) activity of in vitro digested (permeate and retentate fractions) Whey Protein Isolate 92 
(WPI) and Casein Proteins (CP) compared to undigested samples and to soya protein isolate 93 
(CTR). A peptidomic/ proteomic analysis of WPI and CP was also performed to substantiate 94 
the presence of bioactive peptides. Further, the effect of WPI, CP and CTR retentate was tested 95 
on cell metabolic activity and on mucus production (MUC5AC and MUC2 gene expression) in 96 
HT29-MTX-E12 cells as a human intestinal goblet cell model. 97 
MATERIALS AND METHODS 98 
 99 
Samples and reagents 100 
The samples tested in the study were the following: Whey Protein Isolate sample (WPI) (Volac 101 
Int Ltd, Cambridge) with a protein content of 93g/100g protein; Calcium caseinate (casein 102 
protein, CP, Garret Ingredients) with a protein content of 90g/100g protein; and soya protein 103 
isolate (CTR)  (MyProtein, Northwich) with a protein content of 90g/100g. 104 
In vitro digestion  105 
Whey protein isolate, CP and CTR in vitro digestion was performed according to the method 106 
of Minekus et al. (2014), and further adapted by our group (Giromini et al., 2017).  107 
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Briefly, 20 g of WPI, CP or CTR sample were mixed with 150 mL of distilled H2O and 108 
maintained on an orbital shaker at 150 rpm for 5 minutes. The digestion procedure involved 109 
three phases. For the oral phase 6.66 mg α-amylase in 2.1 mL of 1 mM CaCl2, pH 7 was added 110 
to the samples and they were incubated for 30 min at 37 ◦C on a shaker. For the gastric phase, 111 
the pH was decreased up to 2 with 6 M HCl and 0.9 g of pepsin in 8.3 mL of 0.1 M HCl was 112 
added. The samples were then incubated for 120 min at 37 ◦C on a shaker. For the small 113 
intestinal phase, the pH was increased to 7 with 6 M NaOH and 0.2 mg pancreatin and 1.2 g 114 
bile in NaHCO3 0.5 M were added to the samples before the final incubation of 180 min at 37 115 
◦C on a shaker was performed.  116 
A blank sample (enzymes of the digestion alone), a positive control and negative control were 117 
included as reference samples and for stability tests in all digestions performed (n=3).  118 
Samples preparation 119 
At the end of the digestion, the total digesta obtained was transferred to 3kDa cut-off membrane 120 
(VIVASPIN 20 Sartorius). Each filter was previously activated with 0.1% BSA solution. 121 
Samples were centrifuged for 20 min at 3500 x g to obtain permeate (peptides and polypeptides 122 
< 3kDa) and retentate (peptide and polypeptides ˃ 3kDa) fractions. Aliquots from  permeate 123 
and retentate fractions were sampled and snap frozen in liquid nitrogen to stop enzyme activity 124 
before storing at -80 °C for further experiments. 125 
Angiotensin-1-converting enzyme inhibitory activity 126 
The ACE1-I of WPI, CP and CTR undigested, permeate and retentate samples was quantified 127 
using the ACE1-I assay with furanacroloyl-Phe-Glu-Glu (FAPGG) as the synthetic substrate 128 
for the ACE1-I enzyme, as described by Giromini et al. (2017). A synthetic specific ACE 129 
inhibitor captopril at the concentration of 20nM was included as control. Data are expressed as 130 
percentage of ACE1-I (% ACE1-I). 131 
Total antioxidant capacity-ABTS assay 132 
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Antioxidant capacity (AOX) was determined in WPI, CP and CTR undigested, permeate and 133 
retentate samples using the method described by Re et al. (1999) with modifications. Trolox 134 
stock solution (2.5 mM in distilled water) was used to produce the standard curve. A solution 135 
of 2,2′-azinobis (3-ethylbenzothiazoline 6-sulfonic acid (ABTS) (7 mM) was prepared with 136 
potassium persulfate (140 mM ) in distilled water and left to react in the dark for 12–16 hours 137 
to produce the ABTS•+solution. For the study of AOX capacity of WPI, CP and CTR permeate 138 
and retentate, the ABTS•+solution was diluted with phosphate buffered saline, pH 7.4, (PBS) 139 
to reach the absorbance of 0.70 (±0.02) at 734 nm and equilibrated at 30°C. A volume of 20µL 140 
of sample or Trolox standard was mixed with 2mL of ABTS•+ working solution and incubated 141 
in dark for 6 min at room temperature before measuring absorbance at 734 nm on the 142 
spectrophotometer. Appropriate solvent blanks were included in each assay. The percentage 143 
inhibition of absorbance at 734 nm was calculated and plotted as a function of concentration of 144 
samples and of Trolox for the standard reference data. AOX results are expressed as µmol 145 
Trolox equivalent (TE)/ mg protein. 146 
Proteomic and peptidomic profile 147 
Permeate and retentate of WPI and CP were analysed by LC-nano ESI tandem mass 148 
spectroscopy using a shotgun-label free approach to identify peptides and proteins. The 149 
permeate was analysed without any digestion before MS/MS to identify endogenous peptides 150 
presents in the samples, the so called peptidomic strategy (Aletti et al. 2016) (Fig. 1) while the 151 
retentate was further digested using sequence-grade trypsin with a protein:protease ratio 20:1 152 
(Iametti et al., 2001) with a proteomic strategy (Fig. 1). The digestion with trypsin is a normal 153 
procedure in the proteomic MS/MS analysis in order to identify the proteins based on the 154 
sequence of the corresponding tryptic peptides. Trypsin generates experimentally observable 155 
peptides that can be used to uniquely identify a protein.  156 
8 
 
Mass analysis was carried out using an LTQ OrbitrapVelos (Thermo Fisher Scientific, Bremen, 157 
Germany) as described in Maffioli et al. (2017) for the peptidomic strategy and in Coccetti et 158 
al., (2008) for the proteomic analysis. 159 
FIGURE 1 160 
Peptidomic and proteomic data analysis 161 
MS spectra were searched against the mammalian NCBI sequence database (release 162 
24.01.2017) (casein and whey samples) by the Sequest search engine contained in the Proteome 163 
Discoverer 1.4.0 software (Thermo Fisher Scientific Inc., USA). The following parameters 164 
were used: 10 ppm for MS and 0.5 Da for MS/MS tolerance, Met oxidation, N-terminal 165 
acetylation and Gln /Asn deamidation as variable modifications. Carbamidomethylation of Cys 166 
as fixed modification and trypsin (2 misses) as protease were parameters further added in the 167 
proteomic analysis. Only peptides with False Discovery Rate 1% (against decoy) and Xcorr 1.5 168 
were included for positive identification (Dell’Orco et al. 2016).  Two replicates were carried 169 
out for each sample in the MS analysis. All peptides were searched in SATPdb (Singh et al. 170 
2016) and BIOPEP-UWM database (Minkiewicz et al 2008), two databases of structurally 171 
annotated therapeutic peptides, to find potentially bioactive peptides. In order to consider 172 
possible further proteolysis, the search was performed keeping a minimum sequence length of 173 
6 amino acids and applying  a “IF” nested function to a matrix which compared the sequence 174 
of each peptide found  with the ones of the database (Microsoft Excel 2016 (version 15.27). 175 
The mass spectrometry proteomics data have been deposited to the ProteomeXchange 176 
Consortium via the PRIDE partner repository (Vizcaino et al 2016) with the dataset identifier 177 
PXD012588 for the permeate and PXD012625 for the retentate. 178 
Cell culture experiments 179 
In our study, the permeate and retentate fractions obtained after IVD reproduced the pool of 180 
peptides generated during the physiological digestion in humans (Giromini et al., 2019). Small 181 
peptides (<3KDa, permeate fraction) could be absorbed by epithelial cells along the small 182 
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intestine and enter the blood circulation, whereas polypeptides (>3KDa, retentate fraction) can 183 
reach the colonic environment. Thus, in a second set of experiments we tested the effect of 184 
WPI, CP and CTR retentate fractions on intestinal HT29-MTX-E12 cell metabolic activity and 185 
mucus production modulation.  186 
Metabolic activity 187 
The HT29-MTX-E12 cells were kindly donated by Dr. Stig Purup, Aarhus University, Research 188 
Centre Foulum, DK. This human colorectal adenocarcinoma cell line, which is a clone of HT29 189 
cells, is able to differentiate into a mucus-producing goblet-like cell line. Cell maintenance was 190 
performed in 25 cm2 flasks using 15 mL Dulbecco’s modified Eagle’s medium (DMEM) with 191 
glucose (4.5 g/L) and supplemented with 10% of FCS, 1% 1 M HEPES, 1% (v/v) 192 
penicillin/streptomycin, 2% Glutamax and 1% MEM NEAA. The cells were cultivated at 37°C 193 
in a humidified incubator with 5% CO2. All experiments were performed using HT29-MTX-194 
E12 cells within six cell passages (passages 40 to 45) to ensure reproducibility. 195 
Undifferentiated HT29-MTX-E12 cells were plated at a density of 1.5x104 cells/well in 96-well 196 
plates and cultured for 24 hours. Whey protein isolate, CP and CTR retentate were diluted in 197 
0.05% FCS DMEM (Giromini et al., 2015) and added to the cell culture at different 198 
concentrations (from 42.62 to 0.16 mg/ml). For the control wells, 0.05% FCS DMEM was 199 
added. 200 
The retentate stock solutions of WPI, CP and CTR contained between 86.23 and 85.24 mg 201 
protein/ml. Stock solutions have been normalised to 85.24 mg/ml, which corresponds to the 202 
lowest protein concentration observed among WPI, CP and CTR. Considering the high 203 
cytotoxicity of stock solutions and the absence of DMEM medium to regulate the osmotic 204 
pressure, we have tested diluted concentrations of retentate from 42.62 up to 0.16mg/ml.  205 
After 3 and 24 hours of treatment, the metabolic activity of HT29-MTX-E12 cells was 206 
evaluated by MTT test. MTT assay measures the production of the chromophore formazan from 207 
3-(4, 5-dimethylthiazol-2-yl)-2, 5 diphenyltetrazoliumbromide (MTT). Formazan is produced 208 
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in viable cells by the mitochondrial enzyme succinate dehydrogenase. Three replicates per 209 
treatment were included and the experiments were repeated three times (n=3). 210 
Specifically, the cell metabolic activity percentage induced by the protein retentate 211 
wascalculated as follows: 212 
% cell metabolic activity = (mean optical density of treated cells / mean optical density of 213 
control cells) x 100. 214 
Mucus production- real-time quantitative PCR (qRT-PCR) 215 
The HT29-MTX-E12 cells were seeded at a density of 5x105 cells/well in 12-well plates and 216 
maintained for up to 21 days in complete medium (Martinez-Maqueda et al., 2012a). Martinez-217 
Maqueda et al. (2012a) reported that, after 21 days of culture, HT29-MTX-E12 cells express a 218 
stable amount of mucus. At day 21, the cells were washed with PBS, and the medium was 219 
replaced with 0.05% FCS DMEM medium for 24 h (cell starvation). The treatment medium 220 
(0.05% FCS) with WPI, CP or CTR protein retentate at different concentrations (0.33 up to 221 
1.33 mg/g) was added to the cells, which were then incubated in a controlled atmosphere (37°C 222 
/ 5% CO2) for 3 hours. The concentration range was chosen based on the MTT test results. 223 
Control cells (0mg/g) were not treated. 224 
qRT-PCR assay was carried out with the real-time fluorescence method using a Strategene 225 
Mx3000p. At the end of 3 hours incubation, total RNA was extracted from the HT29-MTX-226 
E12 cells using a nucleospin RNA II kit (Macherey-Nagel, Duren, Germany) according to the 227 
manufacturer’s protocol. The RNA (50ng) was reverse transcribed using the iScript cDNA 228 
synthesis kit (BioRad), and the resulting cDNA was used as a template for qRT-PCR. MUC5AC 229 
and MUC2 genes were amplified by qRT-PCR with primer sequences that have previously been 230 
published by Martínez-Maqueda et al.(2012a) and Nielsen et al.(2018) (Table 1), and 231 
cyclophilin and β -actin were included as a reference genes. The primers have been checked for 232 
specificity in BLAST before the Real-time PCR experiments.  233 
TABLE 1 234 
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Each reaction tube contained 2X SYBR Green real-time PCR Master Mix, gene-specific 235 
forward and reverse primers and the cDNA (1µl). The master mix included Maxima® Hot Start 236 
Taq DNA polymerase, dNTPs in an optimized PCR buffer, and SYBR® Green I dye 237 
supplemented with ROX passive reference dye. All reactions were analyzed under the same 238 
conditions and normalized to the ROX reference dye to correct eventually fluctuations in the 239 
readings due to evaporation phenomena. The samples were tested in triplicate and non-reverse 240 
transcribed controls and no-template controls were included in the assays. The thermal profile 241 
began with 4 minutes at 95°C followed by 40 cycles of 95 °C for 30 s and 60 °C for 1 minute. 242 
Relative quantification was performed, and the values were normalized to the internal reference 243 
gene cyclophilin. Two internal controls, cyclophilin and β-actin genes were tested as 244 
endogenous genes and cyclophilin was selected because its amplification was more efficient 245 
and had no variation across treatments.  This verified the efficiency of its use as the endogenous 246 
control. 247 
Statistical analysis 248 
Statistical analysis were performed using GraphPad-Prism version 8 software package 249 
(GraphPad Software, San Diego, USA). Data are presented as least square means ± SEM. 250 
ACE1-I and AOX data were analysed using a two-way ANOVA to identify the significant 251 
differences between undigested, permeate and retentate in WPI, CP and CTR. The differences 252 
between means were compared using Tukey’s test and considered statistically significant at 253 
P<0.05. For gene expression analysis, the comparative CT method was used (Livak and 254 
Schmittgen, 2001) to determine the fold changes in gene expression, which were calculated 255 
with the threshold method (2-∆∆CT).  A two-way ANOVA was also performed on cell 256 
metabolic activity and gene expression data and means were compared using Tukey’s test (P< 257 




In vitro digestion 260 
WPI, CP and CTR samples were in vitro digested and the total digesta was filtered with a 3kDa 261 
membrane to obtained a permeate (<3kDa) and a retentate (>3kDa) fraction. The WPI, CP and 262 
CTR permeate fractions were further tested for ACE1-I and AOX activities. The WPI, CP and 263 
CTR retentate fractions were tested for ACE1-I, AOX and cytomodulatory effect. A 264 
peptidomic/proteomic characterization was performed on WPI and CP permeate and retentate 265 
to check the presence of bioactive peptides. 266 
Angiotensin-1-Converting Enzyme Inhibitory activity 267 
Whey protein isolate permeate exhibited the highest ACE1-I effect. In particular, WPI permeate 268 
induced a significant ACE1-I inhibitory effect (49.2 ± 0.64 %) compared with WPI undigested 269 
(P<0.001), CP permeate (P<0.001) and CP retentate (P<0.001) and with CTR permeate (10.40 270 
± 1.07 %; P<0.001). CP permeate induced a significant ACE1-I effect (23.91 ± 0.64%) 271 
compared with CTR permeate (P<0.001), which showed the lowest ACE1-I effect. 272 
FIGURE 2 273 
Total antioxidant capacity-ABTS assay 274 
Whey protein isolate and CP permeate showed a significant increase in AOX (1.58 ± 0.04 and 275 
1.61 ± 0.02 µmol trolox AOX equivalents /mg protein (TrAOX equ/mg P) respectively, 276 
compared with undigested WPI and CP (< 0.6 µmol TrAOX equ/mg protein; P=0.02), CTR 277 
permeate (1.07 ± 0.04 µmol TrAOX equ/mg protein; P=0.04) and WPI, CP and CTR retentate. 278 
Low AOX was observed in CTR retentate (<0.6 µmol TrAOX equ/mg protein). 279 
Proteomic/ peptidomic analysis of digesta 280 
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Based on the results obtained with ACE1-I and AOX activities, WPI and CP permeate and 281 
retentate samples were analyzed for their peptide content. Permeate was characterized by LC-282 
nano ESI MS/MS using a shotgun-peptidomic approach while retentate was further digested 283 
with trypsin and analysed by mass spectrometry with a shotgun-proteomic approach as shown 284 
in Fig.1. The list of the peptides identified in the retentate and permeate of WPI and CP are 285 
reported in the Supplementary Tables S1 (permeate) and S2 (retentate), respectively.  All the 286 
data sets from CP and WPI were searched in SATPdb and BIOPEP-UWM databases taking 287 
into account possible further proteolysis to find potentially bioactive peptides. In accordance 288 
with the results reported above, peptides with ace inhibitory and anti-hypertensive activity were 289 
identified in the WPI permeate together with one peptide with anti-hypertensive properties in 290 
the casein retentate (TPEVDDEALE) (Table 2).   291 
TABLE 2 292 
Cell culture experiments 293 
In our study, the retentate fraction contained molecules with a molecular size larger than 3kDa, 294 
these molecules can reach the colonic tissue and ideally can escape the small intestinal 295 
absorption. There is little evidence that dietary bioactive peptides other than di and tri peptides, 296 
can cross the gut wall and enter the blood circulation. Di-and tri- peptides can be absorbed by 297 
selective transport systems (such as paracellular pathway via tight junctions, passive diffusion 298 
via enterocytes, endocytosis or by carrier-mediated transport systems), larger peptides and 299 
protein particulates may cross the gut wall though only in very small quantities (Miner-300 
Williams et al., 2014). Therefore, we selected the >3kDa retentate fraction for colon cell 301 




The results presented here indicated that all of the protein fractions, at specific concentrations, 304 
were able to modulate the metabolic activity of the HT29-MTX-E12 cells and to exert trophic 305 
effects on the intestinal epithelia. Treatment of HT29-MTX-E12 cell monolayer with WPI, CP 306 
and CTR (soya protein isolate) retentate caused stimulation or reduction of cell metabolic 307 
activity depending on the dosage, as measured by MTT test (mitochondrial activity). As shown 308 
in Figure 3, in the lowest range of concentrations tested (0.16mg/g-1.33mg/g), the CTR 309 
retentate was effective in significantly enhancing HT29-MTX-E12 cell metabolic activity 310 
compared with untreated cells (0 mg/g). In particular after 24 hours, CTR retentate at the 311 
concentrations from 0.16 to 0.66 mg/g significantly enhanced cell metabolic activity (P<0.01). 312 
After 24 hours treatment, CP at the concentration of 0.33 and 0.66 mg/g increased cell metabolic 313 
activity compared with untreated cells (P<0.05); whereas after 3 hours of CP and WPI and after 314 
24 h WPI treatment cell metabolic activity remained unchanged compared with untreated cells 315 
(0 mg/g). Considering the highest concentration range (2.66-21.31mg/g), we observed that, 316 
WPI, CP and CTR retentate reduced the metabolic activity of the HT29-MTX-E12 cells in a 317 
dose-dependent manner. In contrast, CTR retentate after 3 h treatment at the concentration from 318 
2.66 up to 21.31 mg/g maintained cell metabolic activity compared with untreated cells 319 
(0mg/g). 320 
MUC2 and MUC5AC gene expression 321 
FIGURE 4 322 
We cultured HT29-MTX-E12 cells for 3 h in the presence of WPI, CP or CTR retentate. 323 
Specific concentrations of CP retentate modulated the expression of mucins MUC5AC and 324 
MUC2 in HT29-MTX-E12 cells. In particular, CP retentate promoted the expression of 325 
MUC5AC mRNA at 0.33 mg/g (P= 0.02), 0.66 mg/g (P=0.04) and 1.33 mg/g (P= 0.008) 326 
compared with untreated cells (0 mg/g) and with WPI and CTR. MUC5AC mRNA expression 327 
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remained unaltered (P>0.1) by WPI and CTR retentate treatment. CP retentate at the 328 
concentration of 0.33mg/g also promoted the expression of MUC2 mRNA. The MUC2 mRNA 329 
gene expression by WPI and CTR retentate remained unaltered.  330 
DISCUSSION 331 
In the present study we in vitro digested WPI, CP and soya (CTR) proteins to assess their ACE1-332 
I and AOX activities and to study the release of the bioactive peptides.  333 
We reported that permeate and, to a lesser extent, retentate of WPI showed a significant ACE1-334 
I activity compared with undigested WPI, demonstrating that the in vitro digestion influenced 335 
the liberation of ACE1-I peptides. Furthermore, also the permeate fraction of CP showed higher 336 
ACE1-I activity after digestion, confirming the results reported in our previous study where the 337 
ACE1-I activity was tested on a panel of dairy and plant protein supplements (Giromini et al., 338 
2017), and in the study of Petrat-Melin et al. (2015). In the CTR sample, the ACE1-I activity 339 
was significantly reduced in permeate fraction, compared with CTR undigested.  For peptides 340 
to be effective ACE1-inhibitors, they must resist digestion and enter the circulation before 341 
reaching the target organ. Therefore, the bioactivities observed in vitro may not directly 342 
translate into significant effects in vivo, due to the differential bioavailability of peptides in 343 
different individuals. The heterogeneity in individuals’ responsiveness to proteins consumption 344 
can prevent the identification of the association between dietary intakes and health, hinder the 345 
identification of health benefits for specific population groups and limit our understanding of 346 
the exact role of the different bioactive compounds. Moreover, also the absorption step in the 347 
gastro-intestinal environment represents a key point in dairy peptide bioactivity. A bioactive 348 
peptides to exert ACE1-I effect after oral administration must remain intact and active after 349 
intestinal transport and brush border peptidases contact. 350 
As  reported by Miner-Williams et al (2014), only a few of the great number of milk peptides 351 
with proven antihypertensive activity in vitro have so far proven to be clinically effective in 352 
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vivo. However, our recent studies (Fekete et al., 2016a; 2016b and 2018) demonstrated a 353 
relationship between blood pressure reduction in humans as a result of chronic and acute 354 
consumption of milk proteins-based supplements and their in vitro ACE1-I activity. Those 355 
studies demonstrated a significant decrease in blood pressure in both whey and casein protein-356 
consumers groups, compared with the control group (no protein) in a double-blind cross-over 357 
randomized controlled trial. The results reported in the present study further support the 358 
aforementioned outcomes. 359 
In the present study in vitro digestion significantly enhanced AOX capacity of WPI, CP and 360 
CTR as evaluated by ABTS assay. In our experimental conditions, CP permeate and to a lesser 361 
extent WPI permeate showed higher AOX properties, compared with CTR. Caseins have high 362 
content of antioxidant amino acids as tyrosine and tryptophan, the oxidation of which may 363 
quench free radicals inducing AOX effect (Clausen et al., 2009). Clausen et al. (2009) also 364 
reported that caseins are the highest radical scavengers in milk. Di Pierro et al. (2014) reported 365 
that the AOX capacity values for NaCN increased from 0.06 to 0.18 µmol trolox equivalents/mg 366 
protein and for β-casein from 0.51 to 1.19 µmol trolox equivalents/mg protein, after enzymatic 367 
hydrolysis. Petrat-Melin and co-authors (2015) assessed the AOX of in vitro digested β-casein 368 
variants and they reported a significant increase in AOX capacity upon digestion. The AOX 369 
capacity exhibited by the permeate of WPI, CP and CTR in this study enforces the claim that 370 
food proteins are a natural source of AOX compounds. The distinct AOX properties of our 371 
samples may be attributed to the specificity of the peptides or amino acids released from WPI, 372 
CP and CTR primary sequences. 373 
Based on ACE1-I and AOX activity results, we further analysed WPI and CP permeate and 374 
retentate for their bioactive peptide content. In accordance with the results reported above, 375 
peptides with ACE1-I and anti-hypertensive activity were identified in the WPI permeate 376 
together with one peptide with anti-hypertensive property in the CP retentate. Only a few of 377 
previous studies, such as those conducted by Petrat-Melin and co-authors (2015), assessed the 378 
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release of bioactive peptides after digestion. A lack of information about the comparison 379 
between the protein bioactivity and the effective release of peptides associated to that 380 
bioactivity exists. Therefore, the present study compared the biological activities of the digested 381 
proteins with the identification of bioactive peptides.  All together our data confirm WPI is a 382 
rich source of ACE1-I peptides with tested bioactivity, produced upon digestion. Casein protein 383 
permeate showed a significant ACE1-I activity upon digestion, although no bioactive peptides 384 
associated to this activity have been found in permeate. With regard to antioxidant capacity, 385 
although we observed a significant increase of AOX capacity after protein digestion, we did 386 
not identify peptides associated to this bioactivity. This may be due to analytical limitations 387 
associated with MS peptide identification as our method allowed to identify 6 or more amino 388 
acids long peptides, shorter peptides or single amino acids may have not being identified. 389 
A step forward in peptidomic analysis will be also to test ACE1-I peptides from WPI and CP 390 
for their absorption capacity and for their ability of preserving their bioactivity after absorption 391 
and cell internalization. This will massively help in the design of nutritional strategies to prevent 392 
cardiovascular disease or to standardize the industrial production of ACE1-I peptides obtained 393 
by enzymatic hydrolysis.  394 
In our study, the retentate fraction contained molecules with a molecular size larger than 3kDa, 395 
these molecules can ideally escape the small intestinal absorption and reach the colonic tissue. 396 
There is little evidence that dietary bioactive peptides other than di and tri peptides, can cross 397 
the gut wall and enter the blood circulation. Di-and tri- peptides can be absorbed by selective 398 
transport systems (such as paracellular pathway via tight junctions, passive diffusion via 399 
enterocytes, endocytosis or by carrier-mediated transport systems), larger peptides and protein 400 
particulates may cross the gut wall though only in very small quantities (Miner-Williams et al., 401 
2014). Therefore, we selected the >3kDa retentate fraction for colon cell experiments.  402 
Whey protein isolate ,CP and CTR retentate at the lower range of concentrations, maintained 403 
or stimulated metabolic activity of undifferentiated HT29-MTX-E12 intestinal cells; whereas 404 
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metabolic activity. Several food-derived peptides have been described to exert potential chemo-406 
preventative properties against the viability of malignant cells (Meisel and FitzGerald, 2003; 407 
Fernández-Tomé et al., 2018). In this respect, the inhibitory role that we detected may be 408 
interesting from the perspective that the HT29-MTX-E12 cells have a cancerous origin. 409 
Moreover, we observed a hormetic effect induced by CTR retentate (3 and 24 hours treatment) 410 
and, to a lesser extent, by CP retentate (24 hours treatment) in HT29-MTX-E12 cells. The 411 
hormetic response is defined as a biological phenomenon whereby a stimulatory effect results 412 
from exposure to low doses of a compounds that is otherwise inhibitory when given to a cell at 413 
higher doses (Calabrese and Baldwin, 2002; Purup and Nielsen, 2012).  414 
In general, in vitro cell-based models represent an effective tool to test nutritional ingredients 415 
for food and feed evaluation (Cheli et al., 2015; Giromini et al., 2016; Fusi et al., 2018). Cell 416 
culture studies have provided increasing evidence that milk-derived bioactive peptides 417 
modulate metabolic activity, differentiation and/or apoptosis of different cell types (Hartmann 418 
and Meisel, 2007). Pecorini and co-authors (2009) demonstrated that lactoferrin could be 419 
involved in regulating the growth of both intestinal and mammary epithelial cells. Purup et al. 420 
(2007) showed that whey fractions from bovine milk stimulated intestinal cells growth. 421 
Furthermore, Meisel and FitzGerald (2003) hypothesized that milk peptides can cooperatively 422 
stimulate the viability of intestinal cells, thus, the development of the digestive tract. In a recent 423 
study, Purup and co-authors (2018) demonstrated that both casein and whey based supplements 424 
exerted proliferative effects on intestinal cells, in agreement with our study. Tonolo et al. (2018) 425 
reported the ability of milk peptides to increase cell proliferation. In general, cell proliferation is 426 
an essential mechanism for the re-establishment of the surface epithelium after injury and food 427 
proteins may have an important role in prevention and in the recovery of gut tissue integrity. 428 
However, whether the herein observed effect on cell metabolic activity is the result of individual 429 
19 
 
peptides activity or of the synergistic activity of a peptide pool produced by in vitro digestion 430 
is at present not known, and would need further investigations. 431 
In our study, CP was able to significantly promote the expression of MUC5AC gene at all 432 
concentrations tested in mucus-producing HT29-MTX-E12 cells (21 days of culture). Further, 433 
we have found a relationship of the MUC2 expression effect of CP to dose: at the highest 434 
concentrations tested, CP reduced MUC2 expression while at the lowest concentration tested 435 
CP significantly improved MUC2 expression. Our results are in agreement with those of 436 
previous studies that have demonstrated the role of milk peptides in the modulation of 437 
gastrointestinal mucus production. Plaisancié et al. (2013) demonstrated that the total peptide 438 
pool from yoghurt modulated cell proliferation and the secretion of mucins in HT29-MTX-E12 439 
cells. Martínez-Maqueda et al. (2013) reported that casein hydrolysate stimulated HT29-MTX-440 
E12 cells and promotes the expression of MUC5AC. The same group demonstrated the mucin-441 
secreting role of whey protein hydrolysate in HT29-MTX-E12 cells: β-lactorphin increased the 442 
synthesis of mucin proteins without eliciting differences in MUC5AC gene expression 443 
(Martínez-Maqueda 2012a). Plaisancié et al. (2015) demonstrated an increase in mucin 444 
secretion and MUC2 and MUC4 gene expression in HT29-MTX-E12. β-casomorphin-7 445 
increases MUC5AC mRNA expression and the secretion of this mucin, as demonstrated by 446 
Zoghbi et al. (2006). α-lactorphin, a whey-derived peptide, showed enhanced expression of the 447 
MUC5AC gene in HT29-MTX-E12 cells (Martínez-Maqueda et al., 2012a). 448 
The main limitation of our gene expression analysis is related to the lack of demonstrating 449 
mucin secretion effect, which may precede gene expression stimulation (Martinez-Maqueda et 450 
al., 2013) in the process of replenishing the intracellular mucin pool of goblet cells. This latter 451 
point requires further analysis.  452 
Overall, the proliferative and gene expression effects we observed in this study require further 453 
investigations before the full influence of milk protein retentate can be determined at the 454 




Our study combines the identification of bioactive peptides by both a peptidomic and a 457 
proteomic approach with in vitro bioactivities evaluated after simulated digestion. In summary, 458 
our data show that whey proteins have the highest angiotensin-1-converting enzyme inhibitory 459 
activity. Further, we found that whey proteins, after in vitro digestion, generate functional 460 
peptides preserved, in particular those related to angiotensin-1-converting enzyme inhibitory 461 
effect. This makes it possible to hypothesise that whey proteins can have similar effect in vivo. 462 
Casein and soya proteins have stimulatory effects on cell metabolic activity in undifferentiated 463 
HT29-MTX-E12 cells and, in particular, we found that casein proteins may promote mucus 464 
related-gene expression in differentiated HT29-MTX-E12 cells. Furthermore, as whey, casein 465 
and soya are effective in quite low concentrations, they may be useful as functional food 466 
ingredients for the treatment of gut injury caused by inflammatory bowel diseases or diarrhoea 467 
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Figure legends: 630 
Figure 1: 631 
Peptidomic and proteomic workflow on casein (CP), whey (WPI) and soy (CTR) proteins. 632 
Retentates and permeates were analyzed by tandem mass spectroscopy using an LTQ 633 
OrbitrapVelos and searched against the mammalia NCBI sequence database (casein and 634 
whey samples) and UniProt  glycine max (soy samples) by Sequest. 635 
 636 
Figure 2: 637 
ACE1- inhibitory effects of undigested (UND), permeate (P) and retentate (R) of WPI, CP and 638 
soy (CTR). Data are normalized on the nitrogen content of each sample and are expressed 639 
as percentage of ACE1-I. The synthetic ACE inhibitor captopril at the concentration of 640 
20nM, included as control, inhibited 97% enzyme activity. Different superscript letters 641 
denote significant differences (P < 0.05). ACEi, angiotensin-converting enzyme-1. 642 
 643 
Figure 3: 644 
Effects of WPI retentate (A), CP retentate (B) and CTR retentate (C) on HT29-MTX-E12 cell 645 
metabolic activity (expressed as cell viability) after 3 and 24 h of treatment. Data are 646 
expressed as means ± SEM. Different superscript letters denote significant differences from 647 
the metabolic activity obtained in the control cells (0 mg/ml) (P < 0.05). 648 
 649 
Figure 4: 650 
Effects of 3 hours treatment with WPI retentate, CP retentate and CTR retentate on MUC5AC 651 
(A) and MUC (B) gene expression in the HT29-MTX-E12 cells (concentrations range 0.33-652 
1.33 mg/g) determined by qRT-PCR. The data are expressed as the relative gene expression 653 
levels relative to the controls (untreated cells, 0 mg/g). Different superscript letters denote 654 
significant differences (P < 0.05).   655 
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Figure 4  668 
  669 
34 
 
  670 
35 
 
Giromini et al. 671 
Table 1 672 







Mucin-2 (MUC 2)  5’- ACCCCAAGCCCTTCTACGAG-3′ 
 3′-GAGTGGATGCCGTTGATGGT-5’ 
Nielsen et al., 2018 
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Table 2 675 
  DataBase Permeate Retentate 
Casein protein (CP) 
Anti hypertensive TPEVDDEALE   TPEVDDEALEK 
  TPEVDDEALE   TPEVDDEALEKFDK 
Whey protein isolate (WPI) 
Anti hypertensive IDALNENK KIDALNENKVLVLDTDYK   
  VLDTDYK KIDALNENKVLVLDTDYK   
  LKPTPEGN VEELKPTPEGNLE   
  VEELKP VEELKPTPEGNLE   
  LKPTPEGN VYVEELKPTPEGNLE   
  VEELKP VYVEELKPTPEGNLE   
  VYVEELKPTPE VYVEELKPTPEGNLE   
Ace inhibitory VLDTDYK KIDALNENKVLVLDTDYK   
  676 
37 
 
Table legends 677 
TABLE 1. Primer sequences used for quantitative real time polymerase chain reaction. 678 
Quantification by SYBR Green was used for all genes. 679 
TABLE 2. List of Anti-hypertensive and ACE-Inhibitory peptides found in WPI and CP 680 
permeate and retentate samples. 681 
TABLE S1: List of the peptides identified in the permeate of Whey protein isolate (WPI 682 
and casein protein (CP).  683 
Permeate was  analysed by LC-nano ESI tandem mass spectroscopy using a shotgun-label free 684 
approach to identify and quantify peptides without any digestion before MS/MS with a 685 
peptidomic approach. MS spectra were searched against the mammalia NCBI sequence 686 
database (release 24.01.2017) (casein and whey samples) and UniProt glycine max (release 687 
21.02.2018) (soy samples) by Sequest. Only peptides with False Discovery Rate 1% (against 688 
decoy) and Xcorr ≥1.5  were included for positive identification .  Two replicates were carried 689 
out for each sample in the MS analysis. PSMs displays the total number of identified peptide 690 
sequences (peptide spectrum matches) for the corresponding protein, including those 691 
redundantly identified. 692 
TABLE S2: List of the peptides identified in the retentate of Whey protein isolate (WPI 693 
and casein protein (CP).  694 
Retentate was  analysed by LC-nano ESI tandem mass spectroscopy using a shotgun-label free 695 
approach to identify and quantify proteins and  peptides with a proteomic approach. MS spectra 696 
were searched against the mammalia NCBI sequence database (release 24.01.2017) (casein and 697 
whey samples) and UniProt glycine max (release 21.02.2018) (soy samples) by Sequest. Only 698 
peptides with False Discovery Rate 1% (against decoy) and Xcorr ≥ 1.5 were included for 699 
positive identification .  Two replicates were carried out for each sample in the MS analysis. 700 
38 
 
PSMs displays the total number of identified peptide sequences (peptide spectrum matches) for 701 
the corresponding protein, including those redundantly identified.  702 
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Table S1 704 
PERMEATE 
   
 
WP1 
     
 
 













Peptide Sequence Modifications XCorr MH+ [Da] # PSMs 
  








N8(Deamidated) 4,55 1890,93682 5 
  




N6(Deamidated) 4,18 1706,80022 2 
  




4,07 1454,73503 1 
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6,03 4535,88361 1 
 
























5,97 3720,59292 1 
 
























5,74 4593,16811 1 
 


























5,70 4644,95571 1 
 
























5,67 4535,15249 1 
 























5,63 4515,94692 1 





















4,63 1703,67278 1 
 









Peptide Sequence Modifications XCorr MH+ [Da] # PSMs 
  
AIVNTVDNPEAsSE S12(Phospho) 4,39 1525,63445 1 
 



















4,25 1988,70659 1 
 















       











4,08 2087,73418 1 
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O88799.1 Zonadhesin;  0,8 1 
 
 


























































































































containing protein 1 
























































































zinc finger protein 
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Table S2 707 
RETENTATE 
   
 
WPI  
     
 
 





















2OXS_A Chain A, Crystal Structure 
Of The Trypsin Complex 
With Benzamidine At High 






































       




     
 
 
























































































Q4GZT4.2 ATP-binding cassette sub-





Peptide Sequence Modifications Xcorr  MH+ [Da] # PSMs 
  
EDIGDEANETEEPSK 
 
3,325044
632 
1662,6938
95 1 
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